Ad
Tuesday, 6 February 2018
In diabetes war, Novo Nordisk aims to break mold with new pill
LONDON (Reuters) - After nearly a century building a company worth $125 billion based on injectable drugs, Denmark's Novo Nordisk - the world's biggest insulin maker - wants to prove this year it can transform the diabetes market with a pill.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment